Z. Jedličková

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

H. Kolb, B. Hertenstein, C. Koenecke, 2016, Bone Marrow Transplantation.

Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.

E. Holler, H. Greinix, G. Kobbe, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors.

G. Bug, R. Schwerdtfeger, H. Baurmann, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study

T. Stübig, R. Schwerdtfeger, M. Schleuning, 2009, Bone Marrow Transplantation.

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

H. Serve, A. Wolf, P. Bader, 2015 .

Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia

H. Serve, A. Bacigalupo, T. Berg, 2016, Annals of Hematology.

Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors.

G. Bug, R. Schwerdtfeger, H. Baurmann, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.